Methylphenidate (Collegium Pharmaceutical)

N/A

Report date: 2025/01/26 16:25:29
NME

Base Information

Drug NameMethylphenidate (Collegium Pharmaceutical)
Drug Alias NameADHD Therapy (Collegium Pharmaceutical)methylphenidateCOL-171
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 agonists
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCollegium Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesCollegium Pharmaceutical Inc
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with Hyperactivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A